Temporal Rac1 – HIF-1 crosstalk modulates hypoxic survival of aged neurons by Güntert, Tanja et al.








Temporal Rac1 – HIF-1 crosstalk modulates hypoxic survival of aged neurons
Güntert, Tanja ; Gassmann, Max ; Ogunshola, Omolara O
Abstract: Neurodegenerative diseases are frequently associated with hypoxic conditions. During hypoxia
the neuronal cytoskeleton is rapidly reorganized and such abnormalities are directly linked to adverse
outcomes. Besides their roles as master regulators of the cytoskeleton, the Rho GTPases are also involved
in cellular processes stimulated by hypoxic stress. We investigated the contribution of Rac1-mediated
signaling to hypoxic responses of mature neurons using primary cortical cells cultured for 17 days in
vitro. We show Rac1 is both upregulated and activated during hypoxia. Pharmacological inhibition
of Rac1, but not RhoA, completely abrogated hypoxic HIF-1￿ stabilization and expression of the HIF-1
targets VEGF and GLUT1. Furthermore activity of JNK and GSK3￿ were also highly dependent on Rac1
activity and biphasic effects were observed after 6 and 24 h of exposure. Notably, inhibition of either
pathway suppressed HIF-1￿ accumulation. Although inhibition of Rac1 did not affect neuronal viability
during acute exposure cell death was strongly induced after 24 h revealing a time-dependent effect of
Rac1 signaling on survival. Thus hypoxia-activated Rac1 is critical for neuronal HIF-1￿ stabilization and
survival during oxygen deprivation via integration of complex signaling cascades.
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Abstract	  Neurodegenerative	  diseases	   are	   frequently	   associated	  with	  hypoxic	   conditions.	  During	   hypoxia	   the	   neuronal	   cytoskeleton	   is	   rapidly	   reorganized	   and	   such	  abnormalities	   are	   directly	   linked	   to	   adverse	   outcomes.	   Besides	   their	   roles	   as	  master	   regulators	   of	   the	   cytoskeleton,	   the	   Rho	   GTPases	   are	   also	   involved	   in	  cellular	  processes	  stimulated	  by	  hypoxic	  stress.	  We	  investigated	  the	  contribution	  of	   Rac1-­‐mediated	   signaling	   to	   hypoxic	   responses	   of	   mature	   neurons	   using	  primary	   cortical	   cells	   cultured	   for	   17	   days	   in	   vitro.	   We	   show	   Rac1	   is	   both	  upregulated	   and	   activated	   during	   hypoxia.	   Pharmacological	   inhibition	   of	   Rac1,	  but	  not	  RhoA,	  completely	  abrogated	  hypoxic	  HIF-­‐1α	  stabilization	  and	  expression	  of	   the	  HIF-­‐1	   targets	  VEGF	   and	  GLUT1.	   Furthermore	   activity	   of	   JNK	   and	  GSK3β	  were	  also	  highly	  dependent	  on	  Rac1	  activity	  and	  biphasic	  effects	  were	  observed	  after	   6	   and	   24h	   of	   exposure.	  Notably,	   inhibition	   of	   either	   pathway	   suppressed	  HIF-­‐1α	   accumulation.	   Although	   inhibition	   of	   Rac1	   did	   not	   affect	   neuronal	  viability	   during	   acute	   exposure	   cell	   death	   was	   strongly	   induced	   after	   24h	  revealing	   a	   time-­‐dependent	   effect	   of	  Rac1	   signaling	   on	   survival.	   Thus	  hypoxia-­‐activated	  Rac1	   is	   critical	   for	   neuronal	  HIF-­‐1α	   stabilization	   and	   survival	   during	  oxygen	  deprivation	  via	  integration	  of	  complex	  signaling	  cascades.	  	  	  
Keywords:	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  vitro	  	  	  	   	  
	   3	  
1.	  Introduction	  Neurons	  are	  very	  sensitive	  to	  changes	  in	   local	  oxygen	  tension	  due	  to	  their	  high	  oxygen	   consumption	   rates	   (Noh	   et	   al.,	   2012).	   Since	   stroke	   and	   many	  neurodegenerative	   diseases	   are	   also	   characterized	   by	   oxygen	   deprivation	  understanding	   the	   neuronal	   response	   to	   hypoxia	   is	   essential	   to	   develop	  strategies	   to	   prevent	   injury	   or	   improve	   brain	   function	   after	   hypoxic	   insult.	  Adaptation	   to	   hypoxia	   on	   the	   cellular	   level	   is	   largely	   regulated	   by	   the	  transcription	   factor	  hypoxia-­‐inducible	   factor-­‐1	  (HIF-­‐1)	  (Engelhardt	  et	  al.,	  2014;	  Iyer	   et	   al.,	   1998).	   HIF-­‐1	   is	   a	   heterodimer	   that	   consists	   of	   a	   constitutively	  expressed	   HIF-­‐1β	   (also	   known	   as	   aryl	   hydrocarbon	   receptor	   nuclear	  translocation,	   ARNT)	   and	   an	   oxygen-­‐regulated	   HIF-­‐1α	   subunit	   (Wang	   and	  Semenza,	  1995).	  During	  normoxic	  conditions	  HIF-­‐1α	  is	  hydroxylated	  by	  oxygen-­‐dependent	  prolyl	  hydroxylases	  (PHDs)	  -­‐	  a	  modification	  that	  leads	  to	  recognition	  of	  HIF-­‐1α	  by	  the	  von	  Hippel-­‐Lindau	  (VHL)	  protein	  and	  proteasomal	  degradation	  (Cockman	  et	  al.,	  2000).	  When	  oxygen	  levels	  drop	  the	  PHDs	  are	  inhibited,	  HIF-­‐1α	  accumulates	   in	   the	   cytoplasm	   and	   translocates	   into	   the	   nucleus	   where	   it	  dimerizes	  with	   its	  β-­‐subunit	   to	   form	  a	   functional	  HIF-­‐1	  protein	  (Jaakkola	  et	  al.,	  2001;	  Kallio	  et	  al.,	  1998).	  Together	  with	  additional	  co-­‐factors	  HIF-­‐1	  binds	  to	  the	  hypoxia-­‐response	   element	   (HRE)	   of	   its	   target	   genes	   and	   initiates	   their	  transcription	   (Jiang	   et	   al.,	   1996).	   By	   inducing	   glycolytic	   enzymes	   like	  phosphofructokinase	   and	   angiogenic	   factors	   like	   erythropoietin	   and	   vascular	  endothelial	   growth	   factor	  HIF-­‐1	   can	   confer	   tolerance	   to	  hypoxia	   (Bernaudin	   et	  al.,	   2002;	  Engelhardt	   et	   al.,	   2014).	  However	  HIF-­‐1	   contributes	   also	   to	  hypoxia-­‐induced	   cell	   death	   by	   inducing	   pro-­‐apoptotic	   Bcl-­‐2	   family	   members	   or	   by	  stabilizing	  the	  tumor	  suppressor	  p53	  (Halterman	  et	  al.,	  1999;	  Kim	  et	  al.,	  2004).	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Additional	   post-­‐translational	   modifications	   like	   sumoylation	   and	  phosphorylation	   also	   influence	   HIF-­‐1	   stability,	   localization	   and	   transcriptional	  activity	   showing	   that	   its	   regulation	   is	   a	   complex	   process	   (Berta	   et	   al.,	   2007;	  Engelhardt	  et	  al.,	  2014;	  Flugel	  et	  al.,	  2012).	  Rho	  GTPases	  are	  key	  regulators	  of	  the	  cytoskeleton	  but	  additionally	  are	  involved	  in	   various	   cellular	   processes	   including	   survival	   and	   death.	   Interestingly	   some	  family	  members	  are	  regulated	  by	  hypoxia	   in	  a	  manner	  similar	   to	  HIF-­‐1α.	  Rac1,	  RhoA	   and	   Cdc42	   were	   shown	   to	   be	   upregulated	   after	   a	   few	   hours	   of	   oxygen	  deprivation	   (Turcotte	   et	   al.,	   2003)	   and	   it	  was	  demonstrated	   that	   different	  Rho	  GTPases	   regulate	   the	   stabilization	   of	   HIF-­‐1α	   in	   different	   non-­‐brain	   cell	   types	  during	  hypoxia	   (Xue	   et	   al.,	   2006;	   Zhang	   et	   al.,	   2009).	   Indeed	  hypoxia-­‐activated	  Rac1	  is	  crucial	  for	  HIF-­‐1	  activity	  in	  Hep3B	  cells	  (Hirota	  and	  Semenza,	  2001)	  and	  in	   turn	   HIF-­‐1	   binds	   to	   the	   Rac1	   promoter	   and	   enhances	   its	   expression	   in	  pulmonary	  artery	  smooth	  muscle	  cells	  (Diebold	  et	  al.,	  2010).	  Particularly	  in	  the	  brain	  however	  it	  is	  unclear	  whether	  a	  similar	  interaction	  between	  Rac1	  and	  HIF-­‐1	  exists	  and/or	  via	  which	  pathways	  the	  proteins	  might	  be	  connected.	  	  This	   study	   investigated	   whether	   Rac1	   modulates	   HIF-­‐1-­‐driven	   hypoxic	  adaptation	  of	  mature	  primary	  cortical	  neurons	  and	  aimed	  to	  identify	  candidates	  that	  mediate	  the	  crosstalk	  between	  those	  pathways	  to	  gain	  a	  better	  insight	  into	  mechanisms	  of	  neuronal	  death	  during	  oxygen	  deprivation.	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2.	  Results	  
2.1	  Rac1	  is	  upregulated	  and	  activated	  by	  hypoxia	  It	  has	  been	  shown	  in	  different	  cancer	  cell	   lines	   like	  Caki-­‐1,	  MKN-­‐45	  and	  HepG2	  (Turcotte	   et	   al.,	   2003;	   Xue	   et	   al.,	   2006)	   that	   Rac1	   is	   induced	   by	   hypoxia.	   We	  exposed	  mature	  primary	  cortical	  mouse	  neurons	  to	  1%	  oxygen	  for	  short	  periods	  of	   time	   to	   investigate	   if	   neuronal	   Rac1	   is	   similarly	   modulated.	   Western	   blot	  analysis	   and	   quantification	   showed	   that	   4h	   and	   6h	   of	   hypoxia	   increased	   Rac1	  protein	   levels	   compared	   to	   normoxic	   control	   samples	   (Fig.	   1A).	  Immunocytochemistry	  confirmed	  this	  observation.	  Normoxic	  cells	  showed	  very	  weak	  staining	  for	  Rac1	  whereas	  hypoxic	  cells	  gave	  a	  bright	  and	  clear	  signal	  (Fig.	  1B).	   Rac1	   G-­‐LISA	   further	   demonstrated	   that	   activation	   of	   Rac1	   is	   hypoxia-­‐dependent.	  Increased	  Rac1	  activity	  was	  observed	  after	  2h	  (142.8	  ±	  7.2;	  p<0.01)	  and	   remained	  elevated	  up	   to	  6h	   (147.9	  ±	  18.5;	  p<0.01)	   compared	   to	  normoxic	  controls	   (Fig.	  1C).	  Thus	  hypoxia	  not	  only	  elevates	  neuronal	  Rac1	  protein	   levels	  but	  also	  increases	  its	  activity.	  	  	  
2.2	  Rac1	  is	  crucial	  for	  HIF-­‐1-­‐driven	  adaptive	  hypoxic	  response	  Since	   Rac1	   is	   strongly	   induced	   by	   oxygen	   deprivation	   we	   pharmacologically	  investigated	   its	   contribution	   to	   the	   neuronal	   hypoxic	   response.	   As	   expected,	  Western	  blot	  analysis	  showed	  stabilized	  HIF-­‐1α	  protein	  after	  4h	  and	  6h	  hypoxic	  exposure	  however	  treatment	  with	  a	  specific	  Rac1	  inhibitor	  completely	  abrogated	  HIF-­‐1α	  accumulation	  (Fig.	  2A).	  In	  contrast	  a	  RhoA	  inhibitor	  had	  no	  major	  effect	  on	  HIF-­‐1α	   stabilization	   (Supplementary	   Fig.	   1A).	   Immunostaining	   also	   showed	  basal	   nuclear	   normoxic	  HIF-­‐1α	   levels	  were	   increased	  during	  hypoxic	   exposure	  and	   that	   Rac1	   inhibition	   strongly	   suppressed	   hypoxic	   nuclear	   HIF-­‐1α	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accumulation	  (Fig.	  2B).	  To	  further	  confirm	  that	  Rac1	  is	  required	  for	  HIF-­‐1-­‐driven	  hypoxic	  adaptation,	  expression	  of	  HIF-­‐1α	  and	  its	  target	  genes	  GLUT1	  and	  VEGF	  was	   analyzed	   by	   quantitative	   real-­‐time	   PCR	   (Fig.	   2C&D).	   Normoxic	   mRNA	  expression	   levels	   of	   both	   proteins,	   as	   well	   as	   HIF-­‐1α	   mRNA	   levels	  (Supplementary	   Fig.1B),	   were	   unaltered	   by	   Rac1	   blockade.	   Notably,	   inhibitor	  treatment	  abrogated	  hypoxia-­‐induced	  expression	  levels	  of	  both	  GLUT1	  and	  VEGF	  within	  4h	  exposure	  	  (3.37	  ±	  0.36	  and	  8.71	  ±	  0.97	  fold	  respectively;	  p<0.01,	  (Fig.	  2C&D).	  Thus	  Rac1	  is	  a	  potent	  regulator	  of	  neuronal	  HIF-­‐1-­‐driven	  cellular	  hypoxic	  responses.	   Hypoxic	  HIF-­‐1α	  mRNA	   levels	   remained	   unchanged	   (Supplementary	  Fig.1B).	  	  	  
2.3	  JNK	  is	  involved	  in	  Rac1-­‐dependent	  HIF-­‐1α	  regulation	  	  Rac1	  activates	  JNK	  signaling	  cascades	  (Minden	  et	  al.,	  1995)	  and	  in	  HeLa	  cells	  JNK	  phosphorylation	  during	  hypoxia	  was	  important	  for	  HIF-­‐1	  transcriptional	  activity	  (Comerford	  et	  al.,	  2004).	  Since	  protein	  levels	  of	  prolyl	  hydroxylase	  2	  (PHD2)	  and	  von	  Hippel	  Lindau	  (VHL),	  proteins	  known	  to	  be	   involved	   in	  HIF-­‐1	  degradation,	  were	   also	   largely	   unchanged	   (Supplementary	   Fig	   1C&D),	  we	   assessed	  whether	  neuronal	  Rac1-­‐driven	  HIF-­‐1α	  stabilization	  could	  be	  mediated	  by	  JNK.	  After	  4h	  of	  hypoxia	  phospho/total	  JNK	  levels	  were	  marginally	  elevated	  (120.6	  ±	  4.6	  p<0.05).	  Treatment	   with	   50	   or	   100	   μM	   Rac1	   inhibitor	   dramatically	   decreased	   JNK	  phosphorylation	   in	  normoxia	   (50.8	  ±	  6.5;	  p<0.01)	   and	  hypoxia	   (4h:	  76.0	  ±	  7.0,	  p<0.05	  and	  37.8	  ±	  17.5,	  p<0.0001;	  6h:	  72.3	  ±	  13.5	  and	  46.7	  ±	  14.8,	  p<0.01)	  while	  total	   levels	   remained	   constant	   (Fig.	   3A).	   Next,	   to	   determine	   whether	   JNK	   is	  involved	   in	   HIF-­‐1α	   induction,	   we	   treated	   cells	   with	   the	   JNK-­‐specific	   inhibitor	  SP600125	   prior	   to	   hypoxic	   exposure.	   Although	   not	   totally	   prevented,	   hypoxic	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accumulation	   of	   HIF-­‐1α	   was	   significantly	   reduced	   after	   4h	   and	   6h	   by	  approximately	   30%	   (p<0.05)	   compared	   to	   untreated	   controls	   (Fig.	   3B).	  Immunocytochemistry	   confirmed	   these	   findings	   wherein	   hypoxic	   HIF-­‐1α	  staining	  was	  reduced	  by	  JNK	  blockade	  in	  comparison	  to	  untreated	  cells	  after	  6h	  (Fig.	   3C).	   Taken	   together	   neuronal	   JNK	   activity	   is	   dependent	   on	   Rac1	   and	  partially	  contributes	  to	  HIF-­‐1α	  induction	  during	  hypoxia.	  	  
2.4	  Active	  GSK3	  modulates	  hypoxic	  HIF-­‐1α	  accumulation	  in	  neurons	  	  Studies	   in	   HepG2	   cells	   (Flugel	   et	   al.,	   2012)	   suggest	   another	   potential	   link	  between	   Rac1	   and	   HIF-­‐1α	   could	   be	   Glycogen	   synthase	   kinase	   3	   (GSK3).	   We	  assessed	   if	   GSK3β	   -­‐	   the	   isoform	   highly	   expressed	   in	   CNS	   neurons	   -­‐	   is	   Rac1	  dependent	  by	  monitoring	  phosphorylated	  (Ser9)	  and	  total	  GSK3β	  protein	  levels	  with	   and	   without	   Rac1	   inhibition	   (Fig.	   4A).	   After	   6h	   of	   hypoxia	   GSK3β	  phospho/total	  ratio	  was	  significantly	  decreased	  (73.8	  ±	  4.1,	  p<0.05)	  compared	  to	  normoxia.	   In	   contrast	   Rac1	   inhibition	   substantially	   increased	   GSK3β	  phosphorylation	  und	  thus	  inactivated	  the	  kinase	  under	  both	  normoxic	  (208.9	  ±	  68.3)	  and	  hypoxic	  conditions	  (4h:	  up	  to	  272.3	  ±	  84.2	  p<0.01;	  6h:	  up	  to	  353.6	  ±	  98.7	   p<0.0001)	   compared	   to	   untreated	   controls.	   Next,	   we	   inhibited	   GSK3	   by	  treating	  cells	  with	  lithium	  chloride	  (LiCL,	  Fig.	  4B)	  or	  SB216763	  (Fig.	  4C)	  prior	  to	  hypoxic	  exposure	  to	   investigate	  whether	  Rac1-­‐dependent	  modulation	  of	  GSK3β	  could	   modulate	   HIF-­‐1α	   induction.	   Both	   LiCl	   and	   SB216763	   dose	   dependently	  reduced	  hypoxic	  HIF-­‐1α	  accumulation	  after	  4h	  and	  6h	  and	  reduced	  hypoxic	  HIF-­‐1α	   nuclear	   localization	   in	   comparison	   to	   untreated	   controls	   (Fig.	   4C&D).	   Thus	  Rac1-­‐induced	   GSK3	   activation	   also	   contributes	   to	   neuronal	   HIF-­‐1α	   hypoxic	  induction.	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2.5	  Rac1	  regulates	  PI3K/AKT	  pathway	  GSK3	  is	  a	  direct	  target	  of	  AKT	  that	  in	  turn	  is	  regulated	  by	  phosphatidylinositol	  3-­‐kinase	   (PI3K)	   (Cross	   et	   al.,	   1995).	   Since	   PI3K	   is	   also	   associated	   with	   Rac1	  signaling	   (Lin	   et	   al.,	   2011;	   Zhu	   and	   Nelson,	   2013)	   we	   measured	   changes	   in	  phosphorylation	   of	   both	   PI3K	   and	   AKT	   after	   Rac1	   inhibition.	   Interestingly	  phosphorylation	  of	  the	  p85	  regulatory	  subunit	  of	  PI3K,	  widely	  used	  to	  determine	  PI3K	  activity,	  was	  largely	  unaltered	  by	  Rac1	  blockade	  or	  decreased	  oxygen	  levels	  (Supplementary	   Fig.	   2).	   However	   phosphorylation	   of	   p55,	   another	   regulatory	  subunit	  of	  PI3K,	  was	  dose-­‐dependently	  enhanced	  in	  cells	  treated	  with	  the	  Rac1	  inhibitor	  (Fig.	  5A)	  with	  levels	  increasing	  more	  than	  2	  fold	  (p<0.05)	  in	  normoxia	  and	   up	   to	   3	   fold	   (p<0.05)	   in	   hypoxia	   compared	   to	   controls	   (Fig	   5A).	   Similarly	  AKT	  phosphorylation	  was	  strongly	  induced	  by	  Rac1	  inhibition	  in	  both	  normoxia	  and	  hypoxia	  (Fig	  5B).	  	  	  
2.6	  Neurons	  survive	  acute	  hypoxia	  without	  a	  HIF-­‐1-­‐driven	  adaptive	  
response	  	  In	   the	  absence	  of	  Rac1,	  neurons	   failed	   to	   induce	  pathways	   important	   for	  HIF-­‐1	  stabilization	   and	   hypoxic	   adaptation.	   We	   directly	   evaluated	   whether	   Rac1	  inhibition	   alters	   neuronal	   survival	   during	   hypoxia.	   MTT	   results	   show	   Rac1	  blockade	   in	   normoxia	   or	   up	   to	   6h	   hypoxia	   did	   not	   significantly	   affect	   enzyme	  activity	   (Fig.	   6A).	   Similarly	   LDH	   levels	   were	   also	   unaltered	   (data	   not	   shown)	  suggesting	   that	   cortical	   neurons	   can	   survive	   acute	   hypoxia	   despite	   absence	   of	  Rac1	  and	  HIF-­‐1	  driven	  adaptive	  gene	  expression.	  Notably,	  RhoA	   inhibition	  had	  no	  effect	  on	  cell	   survival	  at	  any	  of	   the	   time	  points	  studied	  (Supplementary	  Fig.	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3A&B).	  In	  contrast,	  during	  more	  prolonged	  hypoxia	  of	  up	  to	  24h	  both	  LDH	  (Fig.	  6B)	   and	   MTT	   (data	   not	   shown)	   assays	   showed	   sustained	   Rac1	   blockade	  significantly	   increased	   neuronal	   death.	   Concomitantly,	   and	   in	   line	   with	   these	  findings,	   decreased	   phosphorylation	   of	   both	   GSK3β	   and	   AKT	   was	   observed	  indicating	   a	   complete	   reversal	   of	   the	   effects	   seen	   after	   acute	   injury	   (Fig.	   6C).	  Thus	   in	  absence	  of	  Rac1	  &	  HIF-­‐1	  neurons	  can	  survive	  acute	  but	  not	  prolonged	  hypoxic	  exposure.	  
	  
3.	  Discussion	  Neurons	   are	   highly	   sensitive	   to	   oxygen	   deprivation	   and	   hypoxic	   injury	   causes	  significant	   dysfunction.	   This	   study	   demonstrates	   that	   Rac1	   is	   crucial	   in	   this	  response	   modulating	   HIF-­‐1α	   stability	   and	   downstream	   signaling	   in	   fully	  differentiated	  primary	  cortical	  neurons.	  JNK	  and	  GSK3	  participate	  to	  achieve	  full	  HIF-­‐1α	   induction.	   Surprisingly,	  we	   also	   show	   that	  mature	  neurons	   can	   survive	  acute	  hypoxia	  in	  the	  absence	  of	  Rac1	  and	  HIF-­‐1-­‐mediated	  adaptation.	  In	  contrast	  long	  term	  Rac1	  inhibition	  induces	  significant	  cell	  death.	  Rac1	  controls	  hypoxic	  HIF-­‐1α	  accumulation	  in	  different	  cancer	  cell	  lines	  (Gorlach	  et	  al.,	  2003;	  Hirota	  and	  Semenza,	  2001;	  Xue	  et	  al.,	  2006).	  However	  little	  is	  known	  of	   the	   contribution	   of	   Rac1	   to	   the	   hypoxic	   neuronal	   response	   despite	   being	   of	  special	   interest	   to	   combat	   hypoxia-­‐associated	   brain	   injury.	   Our	   data	   shows	  primary	   cortical	   neurons	   respond	   to	   oxygen	   deprivation	   with	   increased	   Rac1	  protein	   levels	   and	   activity	   after	   acute	   exposure	   (up	   to	   6h).	   Similarly	   elevated	  Rac1	  levels	  were	  observed	  during	  comparable	  hypoxic	  exposures	  in	  Caki-­‐1	  cells	  (Turcotte	  et	  al.,	  2003)	  and	  Rac1	  and	  HIF-­‐1α	  protein	  levels	  correlated	  in	  hypoxic	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retinal	  pigment	  epithelial	  cells	  (Zhang	  et	  al.,	  2009)	  and	  HEK293	  cells	  (Hirota	  and	  Semenza,	   2001).	   Neuronal	   Rac1	   inhibition	   completely	   abrogated	   HIF-­‐1α	  stabilization	   and	   accordingly	   expression	   of	   the	   HIF-­‐1	   target	   genes	   GLUT1	   and	  VEGF	  was	   strongly	   suppressed,	   underlining	   that	   neuronal	  Rac1	   is	   required	   for	  full	  induction	  of	  the	  cellular	  response	  to	  acute	  hypoxia.	  Contrary	  to	  observations	  in	  HEK293	  (Hirota	  and	  Semenza,	  2001),	  neuronal	  Rac1	   inhibition	  did	  not	  alter	  HIF-­‐1α	  mRNA	  levels.	  Rac1	   inhibition	   did	   not	   significantly	   impact	   canonical	   regulators	   of	   HIF-­‐1α	  stabilization.	   Both	   PHD2	   and	   VHL	   levels	   remained	   largely	   unchanged	   after	  treatment	  suggesting	  other	  mediators	  and/or	  signaling	  pathways	  must	  make	  an	  important	   contribution	   to	   outcome.	   Significantly	   elevated	   phosphorylation	   of	  neuronal	  JNK	  after	  4h	  of	  hypoxia	  was	  observed	  similar	  to	  other	  studies	  in	  HepG2	  cells	   (Minet	  et	  al.,	  2001),	  N1E-­‐115	  neuroblastoma	  cells	   (Yamauchi	  et	  al.,	  2006)	  and	   hepatocytes	   (Mollen	   et	   al.,	   2007).	   Inhibition	   of	   JNK	   diminished	   HIF-­‐1	  transcriptional	  activity	  in	  HeLa	  cells	  and	  reduced	  HIF-­‐1α	  protein	  levels	  in	  human	  bronchial	   epithelia	   cells	   (Comerford	   et	   al.,	   2004).	   In	   neurons	   equivalent	  outcomes	  were	  observed	  wherein	  JNK	  phosphorylation	  was	  strongly	  decreased	  by	   Rac1	   inhibition	   and	   JNK	   inhibition	   per	   se	   reduced	   HIF-­‐1α	   levels.	   Thus	   in	  mature	   neurons	   hypoxia-­‐induced	   JNK	   activation	   is	   a	   Rac1-­‐driven	   process	   that	  modulates	   HIF-­‐1α	   stabilization.	   Although	   JNK	   was	   suggested	   to	   be	   a	   negative	  factor	   for	  HIF-­‐1α	  accumulation	   in	  primary	   rat	  neurons	   (Antoniou	  et	   al.,	   2010),	  most	   studies	   indicate	   a	   positive	   correlation	   between	   active	   JNK	   and	   HIF-­‐1	  signaling	   similar	   to	   our	   findings.	   Differences	   in	   experimental	   design	   and	   cells	  may	  underlie	  this	  inconsistency.	  
	   11	  
We	   identified	   GSK3β	   as	   another	  mediator	   of	   Rac1-­‐driven	   HIF-­‐1α	   stabilization.	  GSK3β	   is	   particularly	   abundant	   in	   the	   CNS	   (Jin	   et	   al.,	   2006)	   and	   in	   renal	  carcinoma	   cells	   directly	   phosphorylated	   HIF-­‐1α	   thereby	   targeting	   it	   for	  ubiquitinylation	   and	   subsequent	  proteasomal	  degradation	   (Flugel	   et	   al.,	   2007).	  Furthermore,	  GSK3	  is	  a	  direct	   target	  of	   the	  PI3K/AKT	  pathway	  and	   involved	   in	  HIF-­‐1	  regulation	  during	  hypoxia	  (Zhong	  et	  al.,	  2000),	  and	  tightly	  associated	  with	  Rac1	  signaling	   in	  COS	  7	  and	  natural	  killer	  cells	   (Jiang	  et	  al.,	  2001;	  Murga	  et	  al.,	  2002).	   Neuronal	   Rac1	   blockade	   strongly	   increased	   GSK3β	   serine	  phosphorylation	   and	  abrogated	  HIF-­‐1α	  accumulation	  whereas	  direct	   inhibition	  of	   GSK3	   suppressed	   HIF-­‐1α	   stabilization.	   Hence	   in	   neurons	   hypoxia,	   Rac1	  activation,	   HIF-­‐1α	   induction	   and	   GSK3	   activation	   are	   positively	   correlated.	  Interestingly,	   in	  non-­‐neuronal	   cells,	   increased	   serine	  phosphorylation	  and	   thus	  inactivation	  of	  GSK3	  has	  been	  correlated	  with	  enhanced	  HIF-­‐1α	  levels	  (Flugel	  et	  al.,	   2012;	   Schnitzer	   et	   al.,	   2005).	   Thus	   we	   demonstrate	   for	   the	   first	   time	   that	  active	  GSK3	  can	  contribute	  to	  acute	  hypoxic	  HIF-­‐1α	  stabilization.	  Future	  studies	  need	   to	   explore	   the	   molecular	   mechanisms	   of	   this	   likely	   cell	   type	   specific	  signaling	  event.	  A	  major	   regulatory	   pathway	   of	   GSK3	   activity	   is	   PI3K/AKT	   (Cross	   et	   al.,	   1995)	  that	  both	  influences	  Rac1	  activity	  (Zhu	  and	  Nelson,	  2013)	  and	  is	  a	  downstream	  target	  of	  Rac1	  (Lin	  et	  al.,	  2011).	  Although	  hypoxia	  had	  no	  effect,	  Rac1	  inhibition	  increased	   phosphorylation	   of	   the	   PI3K	   p55	   subunit,	   an	   isoform	   of	   PI3K	   p85	  enriched	  in	  rodent	  brain	  that	  regulates	  PI3K	  activity	  similar	  to	  p85	  (Inukai	  et	  al.,	  1996;	   Pons	   et	   al.,	   1995).	   Notably,	   this	   occurrence	   correlated	   with	   AKT	  phosphorylation	   after	   Rac1	   blockade	   although	   in	   contrast	   hypoxia	   inactivated	  AKT.	   Therefore	   GSK3β	   inactivation	   could	   underlie	   activation	   of	   the	   PI3K/AKT	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pathway.	   Since	   PI3K	   and	   AKT	   activity	   support	   neuroprotection	   (Zhang	   et	   al.,	  2010)	   such	   crosstalk	   would	   confer	   acute	   hypoxic	   tolerance	   and	   likely	  compensate	  the	  absence	  of	  HIF-­‐1α	  signaling	  at	  least	  in	  the	  short	  term.	  	  In	  general	  HIF-­‐1	   is	  believed	  to	  be	  protective	  during	  acute	  and	  mild	  hypoxia	  via	  expression	  of	   its	   target	  genes	   like	  VEGF	  and	  EPO	  (Engelhardt	  et	  al.,	  2014).	  The	  fact	   that	  we	   did	   not	   observe	   any	   alterations	   in	   neuronal	   survival	   during	   6h	   of	  hypoxia	  might	  be	  surprising	  at	  first	  glance,	  but	  several	  studies	  demonstrate	  that	  even	  sensitive	  cells	   like	  neurons	  do	  not	  undergo	  cell	  death	  when	  oxygen	   levels	  are	   above	   0.5	   %.	   For	   example	   differentiated	   RN46A	   neuronal	   cells	   survived	  exposure	   to	  1%	  oxygen	   for	  48h	   (Zhang	  et	   al.,	   2003)	  and	  anoxic	   cell	  death	  was	  induced	  in	  primary	  cortical	  rat	  neurons	  only	  when	  glucose	  concentrations	  were	  decreased	   (Wohnsland	   et	   al.,	   2010).	   We	   did	   observe	   however	   that	   prolonged	  hypoxia	   significantly	   impaired	   survival	   of	   mature	   neurons	   and	   the	   absence	   of	  Rac1	   and	  HIF-­‐1α	   aggravated	   cell	   death.	   Thus	   the	   ability	   of	  mature	   neurons	   to	  survive	   hypoxia	   is	   not	   only	   time	   related	   but	   increasingly	   dependent	   on	  Rac1/HIF-­‐1	   pathway	   activation.	   Interestingly,	   during	   prolonged	   hypoxic	  exposure	  Rac1	  blockade	  reversed	  the	  phosphorylation	  of	  both	  AKT	  and	  GSK3	  –	  AKT	  being	  inactivated	  and	  GSK3	  being	  activated.	  Clearly	  the	  integration	  of	  Rac1	  signaling	  on	  adaptative	  outcome	  is	  highly	  complex	  and	  time-­‐dependent.	  	  Importantly,	  this	  study	  also	  highlights	  that	  the	  effects	  of	  Rac1	  inhibition	  on	  JNK,	  PI3K/AKT	   and	   GSK3β	   activity	   also	   occur	   during	   normoxia	   and	   therefore	  represent	  a	  general	  mechanism	  of	  Rac1	  action.	  As	  such	  we	  can	   infer	   that	  basal	  Rac1	   activity	   is	   essential	   for	   neuronal	   survival.	   However	   it	   is	   also	   clear	   that	  hypoxia-­‐induced	  Rac1	  activity,	  and	  activation	  of	  JNK	  and	  GSK3,	   is	  also	  required	  for	   neuronal	   HIF-­‐1α	   stabilization.	   Thus	   additional	   oxygen	   deprivation	   and	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regulation	  of	  HIF-­‐1	  signaling	  only	  adds	  an	  extra	  degree	  of	  complexity	  to	  both	  the	  signaling	  pathway	  and	  outcome.	  	  In	  conclusion	  Rac1	  plays	  a	  pivotal	   role	   in	   the	  neuronal	  hypoxic	  response	  being	  crucial	  for	  HIF-­‐1α	  accumulation	  via	  activation	  of	  JNK	  and	  GSK3	  pathways.	  Loss	  of	  Rac1	   and	   HIF-­‐1	   during	   acute	   hypoxia	   is	   compensated	   by	   strong	   activation	   of	  PI3K/AKT	  but	   such	   effects	   are	   reversed	  during	  more	  prolonged	   exposure.	   The	  mechanisms	  by	  which	  this	  switching	  occurs	  is	  now	  under	  investigation.	  Overall	  these	   findings	   give	   important	   fundamental	   insights	   into	   neuronal	   hypoxic	  adaptation	  and	  underline	  that	  time-­‐dependent	  alterations	  in	  signaling	  pathways	  have	   strong	   influences	   on	   the	   outcome	   of	   injury.	   More	   emphasis	   and	   gain	   of	  knowledge	   on	   such	   nuances	   will	   definitely	   be	   required	   to	   combat	   neuronal	  damage.	  	  	  
4.	  Experimental	  procedure	  All	   experiments	   were	   performed	   in	   accordance	   with	   Swiss	   animal	   protection	  laws	   and	   University	   of	   Zürich	   institutional	   guidelines	   for	   animal	  experimentation.	  	  
	  
4.1	  Reagents	  and	  Antibodies	  If	   not	   stated	   differently	   chemicals	   and	   reagents	   were	   purchased	   from	   Sigma-­‐Aldrich	   (Missouri,	   USA).	   All	   cell	   culture	   reagents	   were	   purchased	   from	   Life	  Technologies	  (Zug,	  Switzerland).	  The	  following	  antibodies	  were	  used:	  Anti	  HIF-­‐1α	   (NOVUS,	   Littleton,	   USA),	   anti	   Rac1,	   anti	   β-­‐Actin	   (Sigma),	   anti	   TUJ-­‐1	  (COVANCE,	   Berkeley,	   CA,	   USA),	   anti	   phospho-­‐GSK3β	   and	   anti	   total	   GSK3α/β	  (Millipore,	   Billerica,	   MA,	   USA),	   anti	   phospho-­‐JNK	   and	   anti	   total	   JNK	   (R&D	  
	   14	  
Systems,	  Minneapolis,	  MN,	  USA),	  anti	  phospho-­‐p55	  and	  p85	  PI3K	  and	  total	  p85	  PI3K,	  anti	  phospho-­‐AKT	  and	  anti	  total	  AKT	  (Cell	  signaling,	  Danvers,	  MA,	  USA).	  	  
4.2	  Neuronal	  culture	  Primary	  neuronal	   cells	  were	   obtained	   from	   cerebral	   cortex	   of	   C57BL/6	  mouse	  embryos	   at	   gestational	   stage	   E14	   as	   described	   previously	   (Ogunshola	   et	   al.,	  2002).	   Neurobasal	   medium	   was	   complemented	   with	   B27	   supplement	   (1X),	  AlbuMAX	   I	   (0.25g/ml),	   streptavidin-­‐penicillin	   (1%),	   Sodium-­‐Pyruvate	  100U/ml	  and	   L-­‐Glutamine	   (0.5	   mM).	   Cells	   were	   seeded	   on	   poly-­‐L-­‐lysine	   coated	   plastic	  petridishes	   or	   glass	   coverslips	   in	   24	   well	   plates	   (60,000	   cells/cm2).	   Neurons	  were	   maintained	   at	   normal	   atmosphere	   (21%	   O2,	   5%	   CO2)	   in	   a	   humidified	  incubator	  at	  37	  °C	  for	  17	  days.	  Half	  the	  media	  was	  replaced	  every	  6	  days.	  	  	  
4.3	  Hypoxia	  experiments	  and	  inhibitor	  treatments	  For	   hypoxic	   exposure	   cells	   were	   put	   in	   a	   purpose-­‐built	   hypoxic	   glove-­‐box	  chamber	   (in	   vivo	   400,	   RUSKINN	  Technologies,	   Guiseley,	   UK)	   for	   different	   time	  intervals	  (37°C,	  5%	  CO2).	  The	  oxygen	  level	  was	  maintained	  at	  1%.	  Inhibitors	  of	  Rac1	   (Millipore,	   Billerica,	  MA,	  USA)	   and	  RhoA	   (cytoskeleton,	  Denver,	   CO,	  USA)	  were	   added	   just	   prior	   to	   hypoxic	   exposure.	   Inhibitors	   of	   GSK3β	   (SB216763,	  Cayman	  chemicals,	  Ann	  Arbor,	  MI,	  USA;	  LiCl,	  Sigma)	  were	  added	  24h	  before	  and	  JNK	   inhibitor	   SP600123	  was	   added	   1h	   before	   cells	  were	   subjected	   to	   hypoxia.	  Control	  cells	  were	  incubated	  under	  normal	  conditions	  (37°C,	  21%	  O2,	  5%	  CO2).	  	  
4.4.	  Western	  Blot	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Neurons	  were	  lysed	  in	  ice-­‐cold	  lysis	  buffer	  (150	  mM	  NaCl,	  50	  mM	  Tris,	  1%	  Triton	  X-­‐100,	  1%	  NP-­‐40)	  for	  10	  min	  and	  centrifuged	  at	  16	  000	  rcf	  for	  10	  min	  at	  4°C.	  The	  supernatant	  was	  stored	  at	  -­‐20°C.	  Protein	  concentration	  was	  measured	  using	  Bio-­‐Rad	   assay	   according	   to	  manufacturer`s	   instructions.	   40-­‐60	   μg	   of	   protein	  were	  loaded	  on	  SDS-­‐polyacrylamide	  gels	  then	  transferred	  to	  nitrocellulose	  membrane.	  After	  blocking	  in	  0.1%	  TBS-­‐Tween	  with	  5%	  milk	  powder	  or	  5	  %	  BSA	  membranes	  were	   incubated	   overnight	   at	   4°C	   with	   primary	   antibody.	   Membranes	   were	  washed	   then	   incubated	  with	   an	   HRP-­‐conjugated	   secondary	   antibody	   for	   1h	   at	  room	  temperature.	  All	  blots	  were	  normalized	  to	  TUJ-­‐1	  or	  β-­‐Actin	  and	  quantified	  using	  ImageJ	  software.	  	  	  
4.5	  Quantitative	  real-­‐time	  PCR	  (qRT-­‐PCR)	  Total	   RNA	   was	   extracted	   using	   TRIzol	   reagent	   (Invitrogen,	   AG,	   Switzerland)	  according	   to	   the	   manufacturer`s	   protocol.	   Subsequent	   cDNA	   synthesis	   used	  ImProm-­‐II	   Reverse	   Transcription	   System	   (Promega,	   Madison,	   WI,	   USA)	   then	  mouse-­‐specific	   Taq-­‐man-­‐based	   gene	   expression	   assays	   (Applied	   Biosystems,	  Foster	   City,	   CA,	   USA)	   were	   utilized	   to	   perform	   real-­‐time	   PCR	   (HIF-­‐1α	  [Mm00468869_m1];	   VEGF	   [Mm00437304_m1];	   Glut1	   [Mm00441473_m1];	  GAPDH	  [Mm99999915_g1].	  All	   reactions	  were	  run	   in	  duplicate	  using	  ABI	  7500	  RT-­‐PCR	  thermocycler.	  Data	  were	  analyzed	  using	  the	  ΔΔCt-­‐Method.	  	  
4.6	  Immunocytochemistry	  Cells	  were	  fixed	  for	  5	  min	  in	  4%	  paraformaldehyde	  in	  PBS,	  permeabilized	  3	  to	  5	  minutes	   with	   0.1%	   Triton	   X-­‐100	   then	   blocked	   in	   10%	   normal	   goat	   serum.	  Antibodies	   were	   applied	   overnight	   at	   4°C	   followed	   by	   incubation	   with	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fluorescent	   secondary	   antibody	   (AlexaFluor488,	   AlexaFluor594,	   Molecular	  Probes,	   Leiden,	   Netherlands)	   for	   1h	   at	   room	   temperature.	   Cells	   were	  counterstained	   with	   10	   μM	   DAPI	   for	   5	   min.	   For	   F-­‐actin	   staining	   cells	   were	  incubated	   in	   Phalloidin-­‐TRITC	   for	   40	   min	   at	   room	   temperature	   after	   fixation.	  Coverslips	   were	   mounted	   in	   fluorescent	   mounting	   medium	   (Dako,	   Glostrup,	  Denmark)	   then	   viewed	   with	   an	   Axiovert	   fluorescent	   microscope	   (Zeiss,	  Germany).	  
	  
4.7	  Rac1	  activity	  assay	  (G-­‐LISA)	  The	   activation	   of	   Rac1	   was	   assessed	   using	   the	   colorimetric	   G-­‐LISA	   Activation	  Assay	   Biochem	   Kit	   (BK125,	   Cytoskeleton,	   Denver,	   CO,	   USA).	   All	   steps	   were	  performed	  according	  to	  the	  manufacturers	  protocol.	  	  
4.8	  Cell	  death	  assays:	  
4.8.1	   LDH	   assay:	   For	   quantification	   of	   cell	   death	   the	   release	   of	   lactate	  dehydrogenase	   from	   cells	   into	   the	   culture	   medium	   was	   detected	   using	  Cytotoxicity	   Detection	   Kit	   (Roche,	   Penzberg,	   Germany)	   according	   to	   the	  manufacturer`s	  instructions.	  
4.8.2	  MTT	  assay:	  Thiazolyl	   blue	   tetrazolium	   bromide	   (Sigma)	  was	   dissolved	   in	  PBS	  (0.5	  mg/ml)	  and	  added	  to	  cells	   in	  a	  96	  well	   format.	  After	  1h	   incubation	  at	  37°C	  media	  was	  replaced	  with	  100	  µL	  DMSO.	  Absorption	  was	  mearured	  at	  595	  nm	  with	  background	  correction	  at	  670	  nm.	  	  
4.9	  Statistical	  analysis	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All	  graphs	  were	  created	  from	  at	   least	  3	   independent	  experiments	  and	  analyzed	  using	  GraphPad	  Prism	   software.	   All	   error	   bars	   represent	   the	  mean	  ±	   standard	  deviation.	  For	  comparison	  between	  different	  time	  points	  within	  a	  group	  one-­‐way	  ANOVA	  was	  used	  to	  assess	  statistical	  significance	  with	  Tukey	  post-­‐hoc	  test.	  For	  comparisons	  between	  different	  groups	  we	  performed	  two-­‐way	  ANOVA	  followed	  by	  Bonferroni	  post-­‐hoc	  test.	  A	  value	  of	  p<0.05	  was	  considered	  significant.	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Figure	  legends	  
Figure	  1.	  Rac1	  is	  upregulated	  and	  activated	  during	  hypoxia.	  	  Cells	   were	   incubated	   for	   4h	   and	   6h	   under	   normoxic	   (Nx)	   or	   hypoxic	   (Hx)	  conditions.	   A)	   Western	   blot	   and	   quantification	   was	   used	   to	   assess	   total	   Rac1	  protein	   levels,	  TUJ-­‐1	  was	  used	  as	   loading	  control.	   	  B)	  Cellular	  Rac1	   levels	  were	  additionally	   analyzed	   by	   immunocytochemistry;	   green:	   Rac1,	   blue:	   DAPI,	   scale	  bar:	   50	   µm.	   C)	   Rac1	   activity	   was	   determined	   by	   G-­‐LISA.	   **	   p<0.01	   versus	  normoxia.	  Data	  were	   analyzed	  using	  one-­‐way	  ANOVA	   followed	  by	  Tukey	  post-­‐hoc	  test	  (A).	  	  
Figure	  2:	  Rac1	  is	  crucial	  for	  neuronal	  HIF-­‐1α-­‐mediated	  signaling.	  	  Cells	  were	  treated	  with	  50	  or	  100	  µM	  Rac1	  inhibitor	  just	  prior	  to	  normoxic	  (Nx)	  or	  hypoxic	  (Hx)	  exposure.	  A)	  HIF-­‐1α	  protein	  levels	  were	  determined	  by	  Western	  blot,	  TUJ-­‐1	  was	  used	  as	   loading	  control.	  B)	  Normoxic	  and	  hypoxic	  cells	  with	  or	  without	   100	   µM	   Rac1	   inhibitor	   were	   fixed	   and	   immunolabeled	   for	   HIF-­‐1α	  (green)	   and	   counterstained	  with	  DAPI	   (blue).	   Scale	  bar:	  50	  µm.	  TaqMan-­‐based	  RT-­‐PCR	  was	  used	  to	  analyze	  expression	  of	  the	  HIF-­‐1α	  target	  genes	  VEGF	  (C)	  and	  GLUT1	   (B)	   after	   oxygen	   and/or	   inhibitor	   exposure.	   Data	   were	   normalized	   to	  GAPDH	  and	  compared	   to	  normoxic	   control	   sample.	  ** p<0.01	  versus	  normoxic	  control.	   #	   p<0.05,	   ####	   p<0.0001	   comparison	   within	   the	   group.	   Data	   were	  analyzed	  using	  two-­‐way	  ANOVA	  followed	  by	  Bonferroni	  post-­‐hoc	  test.	  	  
Figure	  3:	  JNK	  contributes	  to	  Rac1-­‐dependent	  HIF-­‐1α	  regulation.	  	  A)	   The	   effect	   of	   Rac1	   inhibition	   (50µM	   or	   100	   µM)	   under	   normoxic	   (Nx)	   or	  hypoxic	   conditions	   (Hx)	  on	   JNK	  activity	  was	  assessed	  by	  Western	  blot.	  Results	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display	   the	   ratio	   of	   phosphorylated	   to	   total	   protein	   levels	   normalized	   to	   the	  loading	  control	  TUJ-­‐1	  and	  compared	  to	  the	  normoxic	  control	  sample.	  B)	  Neurons	  were	  pretreated	  with	  50	  µM	  of	  JNK	  inhibitor	  SP600125	  for	  1h	  prior	  to	  hypoxic	  or	  normoxic	  exposure	  and	  HIF-­‐1α	   levels	  were	   compared	   to	  untreated	   samples	  by	  Western	  blot.	  The	  graph	  shows	  HIF-­‐1α	  protein	  levels	  normalized	  to	  the	  loading	  control	  β-­‐Actin	  and	  the	  4h	  hypoxic	  samples	  were	  set	  to	  100%.	  *	  p<0.05	  versus	  Nx	   control;	   #p<0.05,	   ##p<0.01,	   ####p<0.0001	   comparison	  within	   the	   groups.	  Data	   were	   analyzed	   using	   one	   or	   two-­‐way	   ANOVA	   followed	   by	   Tukey	   or	  Bonferroni	   post-­‐hoc	   test.	   C)	   Immunocytochemistry	   assessed	   cellular	   HIF-­‐1α	  levels	   in	   normoxia	   and	   hypoxia	   in	   the	   presence	   or	   absence	   of	   50	   µM	   JNK	  inhibitor	  SP600125.	  Green:	  HIF-­‐1α,	  blue:	  DAPI,	  Scale	  bar:	  50	  µM.	  	  	  
Figure	  4:	  Active	  GSK3β	  is	  critical	  for	  neuronal	  HIF-­‐1α 	  accumulation.	  Cells	  were	  treated	  with	  50	  or	  100	  µM	  Rac1	  inhibitor	  und	  exposed	  to	  4h	  and	  6h	  of	  hypoxia	  (Hx)	  or	  kept	  under	  normoxia	  (Nx).	  A)	  Western	  blots	  were	  performed	  to	  detect	   phosphorylated	   and	   total	   protein	   levels	   of	   GSK3β.	   TUJ-­‐1	   was	   used	   as	  loading	  control.	  GSK3	  was	  inhibited	  by	  treatment	  with	  5	  mM	  and	  10	  mM	  LiCl	  (B)	  or	   5	   µM	   and	   10	   µM	   SB216763	   (C)	   24h	   prior	   to	   hypoxic	   exposure	   and	  HIF-­‐1α	  levels	  were	  analyzed	  by	  Western	  blot	  and	  quantification.	  The	  4h	  hypoxic	  control	  sample	   was	   set	   to	   100%	   and	   β-­‐Actin	   was	   used	   as	   loading	   control.	   Data	   were	  analyzed	  using	  two-­‐way	  ANOVA	  followed	  by	  Bonferroni	  post-­‐hoc	  test. * p<0.05	  versus	   Nx	   control.	   #	   p<0.05,	   ##	   p<0.01,	   ###	   p<0.001	   and	   ####	   p<	   0.0001,	  comparison	  within	  each	  group.	  D)	  Immunocytochemistry	  shows	  cellular	  HIF-­‐1α	  levels	   (green)	   in	   normoxia	   and	   hypoxia	   in	   the	   presence	   or	   absence	   of	   10	  mM	  LiCl.	  Blue:	  DAPI,	  Scale	  bar:	  	  50	  µM.	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Figure	  5:	  Rac1	  may	  regulate	  GSK3β	  activity	  via	  PI3K/AKT	  pathway	  Lysates	  of	  normoxic	  or	  hypoxic	  cells	  treated	  with	  or	  without	  Rac1	  inhibitor	  (50	  and	   100	   µM)	   were	   used	   in	   Western	   blot	   to	   detect	   phosphorylated	   and	   total	  protein	  levels	  of	  PI3K	  p55	  (A)	  and	  AKT	  (B).	  Results	  are	  expressed	  as	  the	  ratio	  of	  phosphorylated	  to	  total	  protein	  and	  data	  is	  normalized	  to	  TUJ-­‐1.	  #	  p<0.05,	  ###	  p<0.001,	   ####	   p<	   0.0001,	   comparison	   within	   the	   group.	   Data	   analysis	   was	  performed	  using	  two-­‐way	  ANOVA	  followed	  by	  Bonferroni	  post-­‐hoc	  test.	  	  
Figure	  6:	  Neurons	  survive	  acute	  hypoxia	  without	  Rac1	  and	  HIF-­‐1α.	  	  Cells	  were	  treated	  with	  Rac1	  inhibitor	  and	  kept	  under	  normoxic	  (Nx)	  or	  hypoxic	  conditions	  (Hx).	  Untreated	  neurons	  were	  used	  as	  control.	  A)	  MTT	  assay	  was	  used	  to	   assess	   the	   effect	   of	   acute	   hypoxia	   (6h)	   and	   inhibition	   of	  Rac1	   on	   cell	   death.	  Data	   analysis	   was	   performed	   using	   two-­‐way	   ANOVA	   followed	   by	   Bonferroni	  post-­‐hoc	   test.	   B,	   LDH	   release	   into	   the	   culture	   medium	   was	   used	   to	   detect	  cytotoxicity	  after	  exposure	  to	  prolonged	  hypoxia	  (24h).	  **	  p<0.01,	  ***	  p<	  0.001	  compared	  to	  Nx	  control.	  ##	  p<0.01,	  comparison	  within	  the	  group	  using	  one-­‐way	  ANOVA	  followed	  by	  Tukey	  post-­‐hoc	  test.	  C)	  Western	  blot	  of	  cell	  lysates	  was	  used	  to	  assess	  HIF-­‐1α	   levels	  and	  changes	   in	  phosphorylation	  of	  GSK3	  and	  AKT	  after	  24h	  hypoxia	  in	  presence	  or	  absence	  of	  Rac1	  inhibitor.	  	  
Supplementary	  Figure	  1:	  Effect	  of	  Rac1	   inhibition	  on	  HIF-­‐1α 	  mRNA	   levels	  
and	  regulators	  of	  HIF-­‐1α 	  stabilization.	  Cells	  were	  exposed	  to	  normoxic	  (Nx)	  or	  hypoxic	  (Hx)	  conditions	  with	  or	  without	  Rac1	   inhibitor	   treatment.	   A)	   RhoA	   inhibition	   (100µM)	   does	   not	   alter	   HIF-­‐1α	  
	   24	  
stabilization.	  B)	  mRNA	  levels	  of	  HIF-­‐1α	  were	  measured	  using	  TaqMan	  based	  RT-­‐PCR.	   Protein	   levels	   of	   PHD2	   (C)	   and	   VHL	   (D)	   before	   and	   after	   Rac1	   inhibition	  were	  assessed	  by	  Western	  blot.	  Data	  were	  normalized	  to	  GAPDH	  and	  compared	  to	  normoxic	  controls.	  Statistical	  analysis	  was	  performed	  using	  one-­‐way	  ANOVA	  followed	  by	  Tukey	  post	  hoc	  test.	  	  
Supplementary	  Figure	  2:	  Effect	  of	  Rac1	  inhibition	  on	  PI3K	  p85	  subunit.	  Phosphorylated	  and	  total	  levels	  of	  PI3K	  p85	  were	  assessed	  by	  Western	  blot.	  The	  quantitative	   graph	   shows	   the	   ratio	   of	   phosphorylated	   to	   total	   p85	   subunit	  compared	   to	   untreated	   normoxic	   control.	   TUJ-­‐1	   was	   used	   as	   loading	   control.	  Statistical	  analysis	  was	  performed	  using	  one-­‐way	  ANOVA	  followed	  by	  Tukey	  post	  hoc	  test.	  
	  
Supplementary	   Figure	   3:	   RhoA	   inhibition	   does	   not	   impact	   neuronal	  
survival.	  MTT	  assay	  was	  used	  to	  measure	  cell	  survival	  after	  acute	  (A)	  and	  prolonged	  (B)	  RhoA	   inhibition.	   **	   p<0.01,	   compared	   to	   Nx	   control.	   Statistical	   analysis	   was	  performed	  using	  one-­‐way	  ANOVA	  followed	  by	  Tukey	  post	  hoc	  test.	  








